Lisata Therapeutics (LSTA) Invested Capital (2016 - 2025)
Lisata Therapeutics' Invested Capital history spans 13 years, with the latest figure at $14.6 million for Q4 2025.
- For Q4 2025, Invested Capital fell 50.2% year-over-year to $14.6 million; the TTM value through Dec 2025 reached $14.6 million, down 50.2%, while the annual FY2025 figure was $14.6 million, 50.2% down from the prior year.
- Invested Capital reached $14.6 million in Q4 2025 per LSTA's latest filing, down from $17.1 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $60.7 million in Q1 2023 to a low of $14.6 million in Q4 2025.
- Average Invested Capital over 3 years is $36.7 million, with a median of $35.7 million recorded in 2024.
- Peak YoY movement for Invested Capital: decreased 29.59% in 2024, then tumbled 50.2% in 2025.
- A 3-year view of Invested Capital shows it stood at $47.9 million in 2023, then tumbled by 38.79% to $29.3 million in 2024, then crashed by 50.2% to $14.6 million in 2025.
- Per Business Quant, the three most recent readings for LSTA's Invested Capital are $14.6 million (Q4 2025), $17.1 million (Q3 2025), and $20.8 million (Q2 2025).